Financials
- Market Capitalization 78.85 M
- Employee 33
- Founded 2011
- CEO N/A
- Website www.elicio.com
- Headquarter Delaware, United States
- FIGI BBG00444GM02
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.09
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4059 | GANX Gain Therapeutics, Inc. - Common Stock | 1.78 USD | -3.78% | -11.00% | +2.30% | -6.81% | 77.69 M USD | ||
| 4066 | CING Cingulate Inc. - Common Stock | 5.44 USD | +0.74% | -0.37% | +20.89% | -11.69% | 79.11 M USD | ||
| 4087 | NRXS Neuraxis, Inc. Common Stock | 5.98 USD | -1.16% | -3.70% | -7.00% | +10.13% | 75.10 M USD | ||
| 4102 | ANVS Annovis Bio, Inc. Common Stock | 1.73 USD | -4.42% | -2.81% | +1.17% | -25.11% | 73.71 M USD |